SCHEMBL6750179

SCHEMBL6750179

COCN1c2cc(C(=O)OC)ccc2Sc2nccnc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.46
TP53 P04637 6/20 0.43
POLB P06746 4/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 3/20 0.41
ALOX15 P16050 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPT P10636 3/20 0.41
LMNA P02545 2/20 0.38
MEN1 O00255 1/20 0.38
PABPC1 P11940 1/20 0.38
APOBEC3A P31941 1/20 0.38
KMT2A Q03164 1/20 0.38
EIF4H Q15056 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
NPSR1 Q6W5P4 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8315505 0.91 HDAC6 (0.45) HDAC6TP53POLBSMN1; SMN2ALDH1A1
SCHEMBL6747463 0.90 HDAC6 (0.44) HDAC6POLBSMN1; SMN2ALDH1A1HSD17B10
SCHEMBL6747555 0.90 HDAC6 (0.44) HDAC6TP53POLBALDH1A1MAPT
SCHEMBL6747320 0.89 HDAC6 (0.57) HDAC6TP53
SCHEMBL6745150 0.88 HDAC6 (0.44) HDAC6TP53POLBSMN1; SMN2KDM4E
SCHEMBL7144340 0.87 HDAC6 (0.42) HDAC6TP53SMN1; SMN2HSD17B10MAPT
SCHEMBL6751846 0.84 HDAC6 (0.39) HDAC6POLBKDM4ELMNATHRB
SCHEMBL6750196 0.83 HDAC6 (0.44) HDAC6SMN1; SMN2KDM4ELMNAMEN1
SCHEMBL6747564 0.83 HDAC6 (0.35) HDAC6TP53POLBSMN1; SMN2KDM4E
SCHEMBL6749176 0.82 LMNA (0.47) HDAC6TP53POLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092737-A1 Benzopiperidine derivatives EISAI CO., LTD. 2004-05-13 US disclosed
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed
EP-0934941-A1 BENZOPIPERIDINE DERIVATIVES Eisai Co., Ltd. (JP) 1999-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092737-A1 Benzopiperidine derivatives HLA-DRB1, HRH1, HRH2 HDAC6 1953/4885TP53 550/4885POLB 2838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.